Clinical implications

P. J. Barnes (London, United Kingdom)

Source: Annual Congress 2007 - Pulmonary biomarkers in COPD
Session: Pulmonary biomarkers in COPD
Session type: Symposium
Number: 1531
Disease area: Airway diseases

PDF journal article, handout or slidesMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. J. Barnes (London, United Kingdom). Clinical implications. Annual Congress 2007 - Pulmonary biomarkers in COPD

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Clinical implications and novel therapies
Source: International Congress 2018 – Accelerated ageing in lungs
Year: 2018

Therapeutic implications
Source: Annual Congress 2009 - The lung cancer-COPD nexus
Year: 2009

Clinical implications of the new concepts regarding COPD pathophysiology
Source: Annual Congress 2008 - New insights into COPD pathophysiology
Year: 2008

Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers
Source: Eur Respir J, 55 (5) 2001028; 10.1183/13993003.01028-2020
Year: 2020

Clinical implications – potential future developments in EBC research
Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate
Year: 2007

Variation among spirometry interpretation algorithms: Clinical implications
Source: Annual Congress 2010 - From diagnosis to disease management in primary care
Year: 2010

Physiologic rationale and clinical pitfalls
Source: Virtual Congress 2021 – High flow nasal cannula in adults with acute respiratory failure
Year: 2021

Therapeutic and management implications
Source: Annual Congress 2010 - Similarities and differences between asthma and COPD: the "Dutch Hypothesis" revisited
Year: 2010

Clinical implications and opportunities for new drug therapies
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
Year: 2008

Clinical approach
Source: Virtual Congress 2021 – ERS guidelines on non-continuous positive airway pressure therapies in obstructive sleep apnoea
Year: 2021

Therapeutic implications
Source: Annual Congress 2011 - Accelerated lung ageing in COPD
Year: 2011

Clinical classification of pulmonary hypertension(PH) and implications for survival
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010

Implications of the exposome and its applicability in clinical and epidemiological studies
Source: International Congress 2016 – Genetics, epigenetics and the exposome
Year: 2016

Ethical aspects of pandemics – clinical implications  
Source: ERS Course 2017 - Acute respiratory pandemics: how to plan for and manage
Year: 2017

Biomarkers for clinical management
Source: International Congress 2017 – PG12 Life-threatening pulmonary infections
Year: 2017

Clinical phenotyping: role in treatment decisions in sarcoidosis
Source: Eur Respir Rev, 29 (155) 190145; 10.1183/16000617.0145-2019
Year: 2020

Clinical implications of host-bacteria-virus interactions in lung transplantation
Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction
Year: 2018